Endothelial cholesterol homeostasis

Endothelial cholesterol homeostasis refers to the physiological regulation of sterol levels within endothelial cells, a process essential for maintaining vascular integrity and function. This homeostasis is governed by the balance between cholesterol uptake via the low-density lipoprotein receptor (LDLR), endogenous synthesis through the HMG-CoA reductase pathway, and efflux mediated by transporters such as ATP-binding cassette transporter A1 (ABCA1) and G1 (ABCG1) (PMID: 30634344). Membrane cholesterol content specifically dictates the biophysical properties of the endothelial cell membrane, including fluidity and the formation of lipid rafts, which serve as platforms for signaling molecules like endothelial nitric oxide synthase (eNOS) (PMID: 11055971). Excessive accumulation of cholesterol in the endothelial membrane leads to increased cell stiffness, reduced nitric oxide bioavailability, and the initiation of pro-inflammatory pathways, all of which are hallmarks of early atherosclerosis (PMID: 25637342). Pharmacological intervention typically involves the use of statins to inhibit synthesis or LXR agonists to promote efflux, while experimental approaches have utilized cyclodextrins to directly extract excess membrane cholesterol to restore endothelial function (PMID: 27510614).

Other names

Endothelial membrane cholesterol contentEndothelial sterol homeostasisVascular cholesterol balance

Modulation of cholesterol biosynthetic pathways, enhancement of reverse cholesterol transport via ABCA1/ABCG1 upregulation, or direct extraction of membrane sterols using cyclodextrins.